FindTrial
Sign In

Autonomic Neuropathy in Type 2 Diabetes Mellitus

Understanding Autonomic Neuropathy in Type 2 Diabetes Mellitus â?? A Prospective Observational Study in Patients Attending Outpatient Clinics of Tertiary Care Hospitals

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/08/020983
Enrollment
100
Registered
2019-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

Kaustav Saha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult diabetic patients 2. Patients of either gender 3. Ambulatory patients 4. Willingness to participate by signing consent form

Exclusion criteria

Exclusion criteria: 1. Not willing to participate in study

Design outcomes

Primary

MeasureTime frame
1. Autonomic neuropathy tests 2. Glycaemic Control in terms of HbA1C, FBG, PPPG 3. Microvascular complications 4. Macrovascular complications 5. Medication adherence 6. Lifestyle modifications Timepoint: 1. At Baseline 2. 6 months 3. 12 Months—

Secondary

MeasureTime frame
1.Basic demographics 2. Comorbidities 3. Screening for nasal symptoms, sweating disturbances, postural fall / dizziness, gastrointestinal symptoms (diarrhoea, constipation, discomfort/ pain) headache, micturition disturbances, impotence, occasional attack of bronchospasm, neuropathic abnormalities. 4. Risk Factors screening for family history of alcoholism, diabetes mellitus, CHD, obesity, smokingTimepoint: 1. At Baseline 2. 6 months 3. 12 Months—

Countries

India

Contacts

Public ContactKaustav Saha

School of Tropical Medicine Kolkata

tripathi.santanu@gmail.com9230566771

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026